Gerardo Rivera-Alfaro

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Randomized Controlled Trial

Systematic Review

Respiratory Syncytial Virus

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

José J Leija-Martínez, Luis A Esparza-Miranda, Gerardo Rivera-Alfaro, Daniel E Noyola
Impact of Nonpharmaceutical Interventions during the COVID-19 Pandemic on the Prevalence of Respiratory Syncytial Virus in Hospitalized Children with Lower Respiratory Tract Infections: A Systematic Review and Meta-Analysis. Viruses 16 (3) (2024)
José J Leija-Martínez, Luis A Esparza-Miranda, Gerardo Rivera-Alfaro, Daniel E Noyola
Impact of Nonpharmaceutical Interventions during the COVID-19 Pandemic on the Prevalence of Respiratory Syncytial Virus in Hospitalized Children with Lower Respiratory Tract Infections: A Systematic Review and Meta-Analysis. Viruses 16 (3) (2024)
José J Leija-Martínez, Luis A Esparza-Miranda, Gerardo Rivera-Alfaro, Daniel E Noyola
Impact of Nonpharmaceutical Interventions during the COVID-19 Pandemic on the Prevalence of Respiratory Syncytial Virus in Hospitalized Children with Lower Respiratory Tract Infections: A Systematic Review and Meta-Analysis. Viruses 16 (3) (2024)
José J Leija-Martínez, Luis A Esparza-Miranda, Gerardo Rivera-Alfaro, Daniel E Noyola
Impact of Nonpharmaceutical Interventions during the COVID-19 Pandemic on the Prevalence of Respiratory Syncytial Virus in Hospitalized Children with Lower Respiratory Tract Infections: A Systematic Review and Meta-Analysis. Viruses 16 (3) (2024)
José J Leija-Martínez, Luis A Esparza-Miranda, Gerardo Rivera-Alfaro, Daniel E Noyola
Impact of Nonpharmaceutical Interventions during the COVID-19 Pandemic on the Prevalence of Respiratory Syncytial Virus in Hospitalized Children with Lower Respiratory Tract Infections: A Systematic Review and Meta-Analysis. Viruses 16 (3) (2024)
Juan Carlos Muñoz-Escalante, Gabriel Mata-Moreno, Gerardo Rivera-Alfaro, Daniel E Noyola
Global Extension and Predominance of Human Metapneumovirus A2 Genotype with Partial G Gene Duplication. Viruses 14 (5) (2022)